financetom
Business
financetom
/
Business
/
Transdigm Group Insider Sold Shares Worth $4,295,128, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Transdigm Group Insider Sold Shares Worth $4,295,128, According to a Recent SEC Filing
Jul 15, 2025 2:16 PM

04:54 PM EDT, 07/15/2025 (MT Newswires) -- W. Nicholas Howley, Director, on July 15, 2025, sold 2,736 shares in Transdigm Group ( TDG ) for $4,295,128. Following the Form 4 filing with the SEC, Howley has control over a total of 21,548 common shares of the company, with 21,548 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1260221/000095017025095903/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: PayPal Planning to Build Ad Business
Market Chatter: PayPal Planning to Build Ad Business
May 28, 2024
07:36 AM EDT, 05/28/2024 (MT Newswires) -- PayPal Holdings ( PYPL ) is planning to build an ad sales business around the data it generates from tracking the purchases and spending behaviors of the millions of consumers who use its services, The Wall Street Journal reported Tuesday. (Market Chatter news is derived from conversations with market professionals globally. This information...
J&J acquires rights to skin disorder drug for $1.25 bln
J&J acquires rights to skin disorder drug for $1.25 bln
May 28, 2024
May 28 (Reuters) - Johnson & Johnson ( JNJ ) said on Tuesday that it had agreed to acquire the rights to an experimental skin disorder treatment from privately held Numab Therapeutics for about $1.25 billion. J&J will acquire Numab's unit for the global rights to the drug, called NM26. (Reporting by Christy Santhosh in Bengaluru; Editing by Anil D'Silva)...
Nordson to Buy Atrion for $460 per Share
Nordson to Buy Atrion for $460 per Share
May 28, 2024
07:37 AM EDT, 05/28/2024 (MT Newswires) -- Nordson ( NDSN ) said Tuesday it has agreed to buy Atrion ( ATRI ) for $460 per share in cash, representing an enterprise value of roughly $800 million. The company, which plans to finance the transaction through cash on hand and newly issued financial debt, said it expects deal completion before its...
Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment
Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment
May 28, 2024
07:37 AM EDT, 05/28/2024 (MT Newswires) -- Satellos Bioscience ( MSCLF ) on Tuesday said it has formed a clinical advisory board comprised of clinical research and drug development experts in genetic muscle disorders, including Duchenne muscular dystrophy. The formation of this clinical advisory board marks a major development step for Satellos as we continue our evolution in becoming a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved